Drug · DIN 00103616 · Veterinary
TYLAN SOLUBLE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 20, 2018; first marketed December 31, 1962.
- Drug Identification Number (DIN)
- 00103616
- Company (DIN owner)
- Elanco Canada LimitedGuelph, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Oral
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TYLOSIN (TYLOSIN TARTRATE) | 100 G | JAR |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 5, 2019: NOC 22600Supplement to a New Drug Submission (SNDS) · Addition of an alternate drug manufacturing and testing site
- February 2, 2018: NOC 20429New Drug Submission (NDS) · Merger - buyout
- January 8, 2018: NOC 20254Supplement to a New Drug Submission (SNDS) · Change to prescription status. labelling updates
- March 13, 2013: NOC 14212Supplement to a New Drug Submission (SNDS) · New species - Honey bees; New indication
- February 23, 2007: NOC 8615Supplement to a New Drug Submission (SNDS) · Change in pre-slaughter withdrawal period (broiler chickens)
- November 8, 2006: NOC 8400Supplement to a New Drug Submission (SNDS) · For a range dosage approval from 110 ppm to 150 ppm for the indication of necrotic enteritis (ne) caused by clostridium perfringens in broiler chickens
- September 22, 2006: NOC 8281Supplement to a New Drug Submission (SNDS) · Change in the pre-slaughter withdrawal period (pigs)
- August 31, 2004: NOC 5323Supplement to a New Drug Submission (SNDS) · Additional claim for swine: as an aid in the treatment of porcine proliferative enteropathy (ppe) or ileitis associated with lawsonia intracellularis
- January 24, 2003: NOC 3618Supplement to a New Drug Submission (SNDS) · As an aid in the treatment of necrotic enteritis caused by clostridium perfringens in broiler chickens